Planning a commercial launch of a biologic into the market is key to its success. In certain instances, there may be a need to get to market much faster than the typical approach. With an experienced CDMO partner, sponsor companies could take their biologic to market within just 30-45 days following regulatory approval.
In this webinar, AstraZeneca and Catalent Biologics will share a case study on a 30-day commercial launch plan for a product into new markets and why this approach was important for patients.
Key Learning Objectives:
- Why to consider a rapid launch
- How to plan a commercial launch and work with partners to meet critical milestones
- Case study on rapid launch of an approved product into new markets
- What challenges to be aware of during execution